Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Cash & Equivalents (2023 - 2025)

Solventum's Cash & Equivalents history spans 3 years, with the latest figure at $878.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 15.22% year-over-year to $878.0 million; the TTM value through Dec 2025 reached $878.0 million, up 15.22%, while the annual FY2025 figure was $878.0 million, 15.22% up from the prior year.
  • Cash & Equivalents reached $878.0 million in Q4 2025 per SOLV's latest filing, down from $1.6 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.6 billion in Q3 2025 to a low of $194.0 million in Q4 2023.
  • Average Cash & Equivalents over 3 years is $796.3 million, with a median of $772.0 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: soared 292.78% in 2024, then crashed 46.39% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $194.0 million in 2023, then skyrocketed by 292.78% to $762.0 million in 2024, then rose by 15.22% to $878.0 million in 2025.
  • Per Business Quant, the three most recent readings for SOLV's Cash & Equivalents are $878.0 million (Q4 2025), $1.6 billion (Q3 2025), and $492.0 million (Q2 2025).